Browsing Other ICR Research by title

14-3-3 Proteins Interact with a Hybrid Prenyl-Phosphorylation Motif to Inhibit G Proteins

Thompson, Andrew (2013-04)

Signaling through G proteins normally involves conformational switching between GTP- and GDP-bound states. Several Rho GTPases are also regulated by RhoGDI binding and sequestering in the cytosol. Rnd proteins are atypical ...

3-D printing in anaesthesia: challenges and controversies

Hartopp, A; Ahmed, I; Miller, G (Wiley, 2017-10)

6p abnormalities and TNF-α over-expression in retinoblastoma cell line

Imbert, I; Coignet, LJA; Pellestor, F (2001)

Retinoblastoma is the most common primary intra-ocular tumor in childhood. It has been established that recurrent cytogenetic abnormalities are the hallmark of mostly all malignant tumors. Recurrent atypical cytogenetic ...

The ability to accumulate deoxyuridine triphosphate and cellular response to thymidylate synthase (TS) inhibition

Aherne, W; Jackman, A (2001-08)

The ability to accumulate deoxyuridine triphosphate and cellular response to thymidylate synthase (TS) inhibition. Thymidylate synthase (TS) is an important enzyme catalysing the reductive methylation of dUMP to dTMP that ...

Abnormal constitutional karyotypes in patients with neuroblastoma: a report of four new cases and review of 47 others in the literature

Satgé, D; Moore, SW; Stiller, CA; Niggli, FK; Pritchard-Jones, K; Bown, N; Bénard, J; Plantaz, D (2003)

Anomalies of constitutional karyotype, which have led to the discovery of oncogenes and tumor-suppressor genes in embryonal tumors such as retinoblastoma and Wilms tumor, have, until recently, rarely been reported until ...

Abnormalities of the p53 Tumour Suppressor Gene in Mature B-cell Neoplasms

Gruszka-Westwood, AM (Taylor & Francis, 2001)

The p53 gene, located on the short arm of human chromosome 17 at 17p13, codes for a 393 aminoacid phosphoprotein, which acts as a transcription factor and is involved in the control of many different cellular processes. ...

Access to clinical trials for adolescents with soft tissue sarcomas: Enrollment in European pediatric Soft tissue sarcoma Study Group (EpSSG) protocols.

Ferrari, A; Trama, A; De Paoli, A; Bergeron, C; Merks, JHM; Jenney, M; Orbach, D; Chisholm, JC; Gallego, S; Glosli, H; De Salvo, GL; Botta, L; Gatta, G; Bisogno, G; RARECAREnet Working Group (2017-06)

BACKGROUND:Adolescents with cancer are enrolled in clinical trials at far lower rates than children. This report compares the number of adolescents (15-19-year-olds) and children (0-14-year-olds) enrolled in the protocols ...

The “Achilles' Heel” of Cancer and Its Implications for the Development of Novel Immunotherapeutic Strategies

Joshi, K; Chain, BM; Peggs, KS; Quezada, SA (Cold Spring Harbor Laboratory, 2018-01)

Activation of Aurora-A Kinase by Protein Partner Binding and Phosphorylation Are Independent and Synergistic

Dodson, CA; Bayliss, R (AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC, 2012-01-06)

Protein kinases are activated by phosphorylation and by the binding of activator proteins. The interplay of these two factors is incompletely understood. We applied energetic analysis to this question and characterized the ...

Active and passive smoking and the risk of breast cancer in women aged 36–45 years: a population based case–control study in the UK

Roddam, AW; Pirie, K; Pike, MC; Chilvers, C; Crossley, B; Hermon, C; McPherson, K; Peto, J; Vessey, M; Beral, V (The Author(s), 2007-06-19)

Acute appendicitis

Baird, DLH; Simillis, C; Kontovounisios, C; Rasheed, S; Tekkis, PP

Adherence to Guidelines for Adult (Non-GIST) Soft Tissue Sarcoma in the Netherlands: A Plea for Dedicated Sarcoma Centers.

Hoekstra, HJ; Haas, RLM; Verhoef, C; Suurmeijer, AJH; van Rijswijk, CSP; Bongers, BGH; van der Graaf, WT; Ho, VKY (2017-10)

Optimal management of soft tissue sarcoma (STS) remains a challenge. A nationwide survey assessed the quality of STS care in the Netherlands, thereby aiming to identify potentialities for improvement through more centralized ...

Adipose-Derived Stem Cells in Aesthetic Surgery: A Mixed Methods Evaluation of the Current Clinical Trial, Intellectual Property, and Regulatory Landscape

Arshad, Z; Halioua-Haubold, C-L; Roberts, M; Urso-Baiarda, F; Branford, OA; Brindley, DA; Davies, BM; Pettitt, D (Oxford University Press (OUP), 2018-01-17)

Adjacent, Adherent, Invaded: A Spectrum of Biologic Aggressiveness Rather Than a Rationale for Selecting Organ Resection in Surgery of Primary Retroperitoneal Sarcomas

Strauss, DC; Renne, SL; Gronchi, A (Springer Science and Business Media LLC, 2018-01)

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial.

Corrie, PG; Marshall, A; Nathan, PD; Lorigan, P; Gore, M; Tahir, S; Faust, G; Kelly, CG; Marples, M; Danson, SJ; Marshall, E; Houston, SJ; Board, RE; Waterston, AM; Nobes, JP; Harries, M; Kumar, S; Goodman, A; Dalgleish, A; Martin-Clavijo, A; Westwell, S; Casasola, R; Chao, D; Maraveyas, A; Patel, PM; Ottensmeier, CH; Farrugia, D; Humphreys, A; Eccles, B; Young, G; Barker, EO; Harman, C; Weiss, M; Myers, KA; Chhabra, A; Rodwell, SH; Dunn, JA; Middleton, MR; AVAST-M Investigators; Nathan, P; Lorigan, P; Dziewulski, P; Holikova, S; Panwar, U; Tahir, S; Faust, G; Thomas, A; Corrie, P; Sirohi, B; Kelly, C; Middleton, M; Marples, M; Danson, S; Lester, J; Marshall, E; Ajaz, M; Houston, S; Board, R; Eaton, D; Waterston, A; Nobes, J; Loo, S; Gray, G; Stubbings, H; Gore, M; Harries, M; Kumar, S; Goodman, A; Dalgleish, A; Martin-Clavijo, A; Marsden, J; Westwell, S; Casasola, R; Chao, D; Maraveyas, A; Marshall, E; Patel, P; Ottensmeier, C; Farrugia, D; Humphreys, A; Eccles, B; Dega, R; Herbert, C; Price, C; Brunt, M; Scott-Brown, M; Hamilton, J; Hayward, RL; Smyth, J; Woodings, P; Nayak, N; Burrows, L; Wolstenholme, V; Wagstaff, J; Nicolson, M; Wilson, A; Barlow, C; Scrase, C; Podd, T; Gonzalez, M; Stewart, J; Highley, M; Wolstenholme, V; Grumett, S; Goodman, A; Talbot, T; Nathan, K; Coltart, R; Gee, B; Gore, M; Farrugia, D; Martin-Clavijo, A; Marsden, J; Price, C; Farrugia, D; Nathan, K; Coltart, R; Nathan, K; Coltart, R (2018-08)

Background:Bevacizumab is a recombinant humanised monoclonal antibody to vascular endothelial growth factor shown to improve survival in advanced solid cancers. We evaluated the role of adjuvant bevacizumab in melanoma ...

Adjuvant chemotherapy may improve disease-free survival in patients with rectal cancer positive for MRI-detected extramural venous invasion following chemoradiation.

Chand, M; Rasheed, S; Heald, R; Swift, I; West, N; Rao, S; Tekkis, P; Brown, G (2017-06)

MRI-detected extramural venous invasion (mrEMVI) is a poor prognostic factor in rectal cancer. Preoperative chemoradiotherapy (CRT) can cause regression in the severity of EMVI and subsequently improve survival whereas ...

Publications Repository

Publications Repository